Dr. Colin Goldschmidt
Chief Executive Officer and Managing Director
Replay available
Sonic Healthcare Ltd (OTC: SKHCF) Q4 2025 earnings conference call, held 2025-08-21. Replay captured from the company's public earnings webcast.

Chief Executive Officer and Managing Director
Deputy Chief Financial Officer, Sonic Healthcare
Chief Financial Officer, Sonic Healthcare
Analyst, RBC Capital Markets
Analyst, MST Marquis
Analyst, Bank of America
Analyst, J.P. Morgan
Analyst, Evans & Partners
Analyst, Jordan
Analyst, Jefferies
Analyst, Goldman Sachs
Analyst, Morgan Stanley
Analyst, Baron Joey
Good day and thank you for standing by. Welcome to the Sonic Healthcare Financial Year ended 30th June 2025 conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 11 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 11 again. Please be advised that today's conference is being recorded. And I'd like to hand the conference over to Dr. Colin Goldschmidt, Chief Executive Officer and Managing Director. Please go ahead, sir. Thank you very much, Amber, and good morning and good day to everyone on the call. Colin Goldschmidt is my name, CEO of Sonic Healthcare, and I'm joined today by my colleagues Chris Wilkes, CFO of Sonic, and Paul Alexander, Deputy CFO of Sonic Healthcare. We're pleased to present our full year results today. And if I could direct you, we'll start the presentation with our headline numbers, which I'm hoping is slide three. I understand last time we were a bit out of sequence with the page numbers. But the headline slide shows a table of our headline results. And just a note on the table itself, the FY2025 numbers are obviously the actual statutory numbers. And we've asterisked the FY2024 comparative numbers to flag that they have been restated to exclude the $32 million gain on the sale of our West Division in the USA. So revenue came in at 9.645 billion, which was up 8% on the prior year. EBITDA came in at 1.725 billion, up 8%. Net profit was 514 million, up 7%. Cash generation came in just shy of 1.3 billion. And earnings per share for the year came in at 106.7 cents. And then moving from statutory to const...